Inhibitor Therapeutics Inc INTI:OTCQB

*Data is delayed | Exchange | USD
Last | 03/28/24 EDT
0.07UNCH (UNCH)
Volume
100,000
52 week range
0.01 - 0.30
Loading...
  • Open0.07
  • Day High0.07
  • Day Low0.07
  • Prev Close0.07
  • 52 Week High0.30
  • 52 Week High Date11/03/23
  • 52 Week Low0.01
  • 52 Week Low Date06/23/23

Key Stats

  • Market Cap12.042M
  • Shares Out172.02M
  • 10 Day Average Volume24,797.86
  • Dividend-
  • Dividend Yield-
  • Beta-0.85
  • YTD % Change-23.91

KEY STATS

  • Open0.07
  • Day High0.07
  • Day Low0.07
  • Prev Close0.07
  • 52 Week High0.30
  • 52 Week High Date11/03/23
  • 52 Week Low0.01
  • 52 Week Low Date06/23/23
  • Market Cap12.042M
  • Shares Out172.02M
  • 10 Day Average Volume24,797.86
  • Dividend-
  • Dividend Yield-
  • Beta-0.85
  • YTD % Change-23.91

RATIOS/PROFITABILITY

  • EPS (TTM)0.03
  • P/E (TTM)2.46
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.555M
  • ROE (TTM)85,981.50%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inhibitor Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Inhibitor Therapeutics, Inc. is a pharmaceutical development company. The Company is focused on developing and commercializing therapeutics for patients with certain cancers and certain non-cancerous proliferation disorders. It also explores acquiring or licensing other pre-clinical and clinical stage therapeutics addressing unmet needs and orphan indications for the treatment of cancer and other diseases. The Company’s primary focus is on the development of therapies...
Francis O'Donnell Jr., M.D.
Executive Chairman of the Board, Chief Executive Officer
James Mcnulty CPA
Chief Financial Officer, Treasurer, Secretary
Address
4830 W. Kennedy Blvd., Suite 600
Tampa, FL
33609
United States

Top Peers

SYMBOLLASTCHG%CHG
EIGR
Eiger BioPharmaceuticals Inc
5.00+0.02+0.40%
JAGX
Jaguar Health Inc
0.0899+0.017+23.3196%
NTII
Neurobiological Technologies Inc
0.00UNCHUNCH
SQZB
SQZ Biotechnologies Co
0.0479+0.0014+2.9247%
SRZN
Surrozen Inc
15.71+1.38+9.64%